Infants at risk with OTC use of benzocaine, says FDA

被引：0

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1407卷 / 1期

关键词：

Public Health; Healthcare Professional; Severe Case; Benzocaine; Difficulty Parent;

D O I：

10.2165/00128415-201214070-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Methaemoglobinaemia risk with OTC benzocaine
Reactions Weekly, 2011, 1347 (1) : 4 - 4
[2] US FDA says withdraw troglitazone
Reactions Weekly, 2000, 795 (1) : 2 - 2
[3] The US FDA says there is not sufficient evidence that SSRI use during pregnancy causes PPHN,*
Reactions Weekly, 2012, 1383 (1) : 4 - 4
[4] The osteoporosis and fracture risk for over the counter (OTC) proton pump inhibitors (PPIs)* has been revoked by the FDA
Reactions Weekly, 2011, 1345 (1) : 3 - 3
[5] New FDA labelling rules increase safety of OTC drugs
Reactions Weekly, 2004, 995 (1) : 2 - 2
[6] Recommendations for OTC cough/cold drugs in infants
Reactions Weekly, 2007, 1174 (1) : 1 - 1
[7] Bisphosphonates and increased AF rates: FDA says no clear link
Reactions Weekly, 2008, 1229 (1) : 3 - 3
[8] US FDA wants balance in risk information
Reactions Weekly, 2009, 1255 (1) : 2 - 2
[9] Use of OTC-drugs prior to Hospitalization
Magnus Pedersen
Mikkel Brabrand
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 21 (Suppl 2)
[10] Toxicity of inadvertent benzocaine for oral use exposures in the pediatric population
Proshek, Crystal
Geller, Robert
Hon, Stephanie
CLINICAL TOXICOLOGY, 2017, 55 (07) : 728 - 728

← 1 2 3 4 5 →